Evidence map›Paper›PMID 33564764›Full record

ArticlebioRxiv : the preprint server for biology2021

Helena Strand Clemmensen, Jean-Yves Dube, Fiona McIntosh, Ida Rosenkrands, Gregers Jungersen, Claus Aagaard, Peter Andersen, Marcel A Behr, Rasmus Mortensen

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Updated by
    2021
  • Updated by
5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Helena Strand ClemmensenDepartment of Infectious Disease Immunology, Statens Serum Institut, Denmark.
Jean-Yves DubeDepartment of Microbiology and Immunology, McGill University, Montréal, Canada.
Fiona McIntoshInfectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, Canada.
Ida RosenkrandsDepartment of Infectious Disease Immunology, Statens Serum Institut, Denmark.
Gregers JungersenDepartment of Infectious Disease Immunology, Statens Serum Institut, Denmark.
Claus AagaardDepartment of Infectious Disease Immunology, Statens Serum Institut, Denmark.
Peter AndersenDepartment of Infectious Disease Immunology, Statens Serum Institut, Denmark.
Marcel A BehrDepartment of Microbiology and Immunology, McGill University, Montréal, Canada.
Rasmus MortensenDepartment of Infectious Disease Immunology, Statens Serum Institut, Denmark.
Statens Serum Institut · DKMcGill University Health Centre · CA

Funding

A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activityR01AI135721 · NIAID · STATENS SERUM INSTITUTE · PI MORTENSEN, RASMUS SKAARUP · 2018 to 2022
$3.5M
NIAID NIH HHS R01 AI135721
6 · The paper itself

Abstract

New vaccines are urgently needed against

Indexed as

ESAT-6in vivo expressionMPT70M. tuberculosisT cell differentiationVaccination

Identifiers

PMID33564764
PMCPMC7872352
OpenAlexW3128470920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.